Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Rate is the Diabetic Neuropathy Market Anticipated to Experience from 2024-2033?

In recent times, the market size for diabetic neuropathy has seen significant growth. It is projected to escalate from $5.4 billion in 2023 to $5.85 billion in 2024, reflecting an 8.4% Compound Annual Growth Rate (CAGR). This growth witnessed in the past period is linked to the global surge in diabetes cases, heightened awareness and diagnosis rates, progress in diabetic care, elevated healthcare spending, investments in research and development, and patient education endeavours.

The market size for diabetic neuropathy is projected to experience substantial growth in the upcoming years, ballooning to $8.42 billion in 2028, with a compound annual growth rate (CAGR) of 9.5%. This growth during the projected period can be credited to the progression in neuroimaging, patient-focused care strategies, an increase in clinical trials, the ongoing upsurge in diabetes occurrences, precision medicine strategies, the broadening of regenerative medicine, and advocacy and support systems for patients. The forecast period will prominently feature collaborative medical research, digital health innovations, evolutionary diagnostic technologies, neuroprotective treatments, customised treatment plans, and the incorporation of artificial intelligence.

Claim Your Free Sample of the Global Diabetic Neuropathy Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9057&type=smp

What Are the Significant Influencers of Growth in the diabetic neuropathy Market?

The increase in diabetes cases worldwide is anticipated to stimulate the diabetic neuropathy market’s development. Diabetes is a chronic condition characterized by the body’s inability to adequately manage and store glucose, a kind of sugar. It emerges when the body’s production of insulin, a hormone crucial for blood sugar regulation, is insufficient or the body doesn’t utilize it properly. Diabetic neuropathy, a nerve damage condition present in diabetics, presents varying symptoms correlating with the kinds of nerve damage. For example, in August 2022, the IDF Diabetes Atlas report, produced by the Belgium-based International Diabetes Federation, a global diabetes community encompassing over 230 national diabetes associations, stated that 6.7 million deaths were due to diabetes in 2021, translating to a death every five seconds. Presently, there are 537 million adults (aged 20–79) living with diabetes, roughly 1 in 10 individuals. Predictions suggest a rise to 643 million by 2030 and 783 million by 2045. Thus, the escalating diabetes prevalence is fueling the expansion of the diabetic neuropathy market.

What Key Segments Define the Diabetic Neuropathy Market?

1) By Disorder: Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy

2) By Drug Class: Analgesics, Anti-Depressants, Anti-convulsants, Other Drug Classes

3) By Treatment: Drug Treatment, Radiotherapy, Physiotherapy, Other Treatments

4) By Distribution Channel: Online Distribution, Offline Distribution

5) By End-user: Hospitals, Specialty Clinics, Other End-users

What Are the Key Developments Shaping the Diabetic Neuropathy Market?

Leading corporations in the diabetic neuropathy marketplace are concentrating their efforts on devising innovative solutions to solidify their market standing. Take for example Nevro Corporation, a medical device enterprise based in the United States, which in July 2021, fostered Senza, also referred to as “HFX”. This high spinal cord stimulation technology caters to the treatment of painful diabetic neuropathy (PDN), an ailment that encumbers up to one-third of Americans with diabetes and triggers sensation loss and leg pain. Their evolved technology Senza® HFX iQTM incorporates artificial intelligence to strategically enhance and sustain pain reduction based on individual patient reactions. It is deliberately structured to account for the variation in pain perception among different individuals and facilitate patients in attaining and preserving prolonged pain relief and an elevation in their standard of living. The comprehensive Senza HFX iQ system, inclusive of the HFX iQ Implantable Pulse Generator (IPG), HFX Trial Stimulator, Charger, and HFX App, stands out as the premier platform to instill algorithms exclusively formulated for addressing chronic lower back and leg pain, including intense diabetic neuropathy and non-surgical backache.

Order Now for Fast Delivery of Your Diabetic Neuropathy Market Report!

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

What Regions Are Driving Expansion in the Diabetic Neuropathy Market?

North America was the largest region in the diabetic neuropathy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the diabetic neuropathy market during the forecast period. The regions covered in the diabetic neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Diabetic Neuropathy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the diabetic neuropathy market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Diabetic Neuropathy Market Include

1. Diabetic Neuropathy Market Executive Summary

2. Diabetic Neuropathy Market Segments

3. Diabetic Neuropathy Market Size And Template Market Growth Rate

4. Key Diabetic Neuropathy Market Trends

5. Major Diabetic Neuropathy Market Drivers

……

25. Key Mergers And Acquisitions In The Diabetic Neuropathy Market

26. Top Diabetic Neuropathy Companies

27. Diabetic Neuropathy Market Opportunities And Strategies

28. Diabetic Neuropathy Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: